The Psychiatric Association of Türkiye Depression Treatment Guidelines - I: Introduction, Terminology, Core Concepts,...

Area of Science:

• Clinical Psychiatry
• Evidence-Based Medicine
• Health Services Research

Background:

• Major Depressive Disorder (MDD) presents complex challenges in treatment planning due to its heterogeneity and evolving therapeutic landscape.
• Existing international guidelines may not fully address the specific clinical needs and context of Türkiye.
• A locally relevant, evidence-based guideline is crucial for guiding clinical decision-making in depression treatment.

Purpose of the Study:

• To develop a scientifically grounded and clinically applicable guideline for the treatment of depression in Türkiye.
• To provide sequential, evidence-based recommendations for managing MDD, including treatment resistance.
• To offer a framework for assessment, subtype classification, outcome measurement, and treatment planning.

Main Methods:

• Systematic review of recent developments in MDD treatment.
• Development of sequential, evidence-based recommendations tailored to Türkiye's clinical context.
• Inclusion of assessment tools, clinical subtypes, outcome measures, and decision-making processes.

Main Results:

• Presents a comprehensive review of current MDD treatment options.
• Offers evidence-based, sequential recommendations for clinical practice in Türkiye.
• Details methodologies for assessment and treatment planning, including for treatment-resistant depression.

Conclusions:

• The guideline addresses a critical gap by providing a locally relevant resource for MDD treatment in Türkiye.
• It facilitates evidence-based clinical decision-making and improves the management of depression.
• The guideline supports standardized approaches to assessment and treatment planning, enhancing patient care.